See the source article by following the link below:
Modified RNA analogs created by a Boston startup to vaccinate cells against cancer and infectious diseases are in Phase I clinical trials
Modified RNA analogs created by a Boston startup to vaccinate cells against cancer and infectious diseases are in Phase I clinical trials
No comments:
Post a Comment